28 Feb 2020 07:00
For immediate release
Â
Circassia Pharmaceuticals plc
Â
Total Voting Rights Update
Â
Â
Â
28th February 2020
Â
In accordance with the requirements of the FCA's Disclosure and Transparency Rule 5.6.1, Circassia Pharmaceuticals plc ("Circassia" or "the Company") (LSE: CIR) confirms that the Company's issued share capital consists of 375,210,543 ordinary shares of 0.08p each in issue, each with equal voting rights. No shares are held in treasury.
Â
The above figure may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interest, or a change to their interest, in the Company under the FCA's Disclosure Guidance and Transparency Rules.
Â
-Ends-
Â
For further information, please contact: | |
 Circassia Pharmaceuticals plc Michael Roller, Company Secretary |  +44 (0) 1865 405560 |
Â
Â